Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stratified Ursodeoxycholic Acid Treatment to Prevent Hepatobiliary and Colorectal Malignancy in Primary Sclerosing Cholangitis
2015-003310-24Phase 3Terminated
- Sponsor
- Sahlgrenska Academy
- Start
- Sep 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of ursodeoxycholic acid in Primary Sclerosing Cholangitis (PSC), hepatobiliary cancer (HBC) and colorectal cancer (CRC) (2 arms), sponsored by Sahlgrenska Academy. Started Sep 2015; status: terminated.
02
Drugs
ursodeoxycholic acid
03
Conditions
Primary Sclerosing Cholangitis (PSC)hepatobiliary cancer (HBC)colorectal cancer (CRC)
Beyond the preview
Go deeper on 2015-003310-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003310-24.